“…The energy-minimized three-dimensional structure of BCI was procured from the NCBI PubChem database. The prepared ligand was computationally screened against calcium sensing receptor (CASR) (PDB ID: 7dtt) [ 21 ], C-X-C chemokine receptor type 3 (CXCR3) (PDB ID: 6wzk) [ 22 ], cyclin-dependent kinase-5 (CDK5) (PDB ID: 1unl) [ 23 ], cathepsin D (CPSD) (PDB ID: 4od9) [ 24 ], casein kinase II subunit alpha (CK2A1) (PDB ID: 6tls) [ 25 ], cyclin-dependent kinase-1 (CDK1) (PDB ID: 6gu2) [ 26 ], dopamine D1 receptor (DRD1) (PDB ID: 7ckx) [ 27 ], dual specificity phosphatase 13a (DUSP13) (PDB ID: 5xjv) [ 28 ], dual specificity phosphatase 14 (DUSP14) (PDB ID: 2wgp) [ 29 ], dual specificity phosphatase 18 (DUSP18) (PDB ID: 2esb) [ 30 ], dual specificity phosphatase 2 (DUSP2) (PDB ID: 1m3g) [ 31 ], dual specificity phosphatase 28 (DUSP28) (PDB ID: 5y15) [ 32 ], dual specificity phosphatase 5 (DUSP5) (PDB ID: 2g6z) [ 33 ], dual specificity phosphatase 6 (DUSP6) (PDB ID: 1hzm) [ 34 ], dual specificity phosphatase 7 (DUPS7) (PDB ID: 4y2e) [ 35 ], dual specificity phosphatase 8 (DUSP8) (PDB ID: 4jmk) [ 36 ], dipeptidyl peptidase IV (DPP4) (PDB ID: 4pv7) [ 37 ], glucagon-like peptide-1 receptor (GLP-1R) (PDB ID: 5vai) [ 38 ], human apurinic/apyrimidinic endonuclease 1 (APE1) (PDB ID: 6bow) [ 39 ], human indoleamine 2,3-dioxygenase-1 (IDO1) (PDB ID: 6e43) [ 40 ], human topoisomerase-II beta (TOP2β) (PDB ID: 3qx3) [ 41 ], intercellular adhesion molecule (ICAM-1) (PDB ID: 5mza) [ 42 ], lysosomal pro-X carboxypeptidase (PRCP) (PDB ID: 3n2z) [ 43 ], Mu opioid receptor (OPRM1) (PDB ID: 4dkl) [ 44 ], plasminogen activator inhibitor type-1 (PAI-1) (PDB ID: 3cvm) [ 45 ], rho-associated protein kinase-1 (ROCK1) (PDB ID: 3v8s) [ 46 ], rho-associated protein kinase-2 (ROCK2) (PDB ID: 6ed6) [ 47 ], serotonin 5a (5-HT5a) receptor (PDB ID: 7x5h) [ 48 ], signal transducer and activator of transcription-3 (STAT3) (PDB ID: 6nuq) [ 49 ], somatostatin receptor 3 (SSTR3) (PDB ID: 7xms) [ 50 ], tripartite motif-containing 24 ...…”